Our study demonstrated that CDK5RAP3 expression was markedly decreased in gastric tumor tissues and led to significantly reduced cancer cell proliferation, migration and invasion and tumor xenograft growth by inhibiting β-catenin. This evidence concerns the gene CDK5RAP3 and gastric neoplasm.